Carmot Therapeutics
Signal active
Organization
Contact Information
Overview
Carmot Therapeutics provides drugs to treat inflammatory, metabolic, and neurological diseases. They employ their patented technology, chemotype evolution, to address the fundamental causes of disease and speed the discovery of disease-modifying therapies.
About
Industries
Biotechnology, Health Care, Therapeutics
Founded
2008
Employees
11-50
Headquarters locations
United States, North America
Social
N/A
Profile Resume
Carmot Therapeutics headquartered in United States, North America, operates in the Biotechnology, Health Care, Therapeutics sector. The company focuses on Biotechnology and has secured $36.9B in funding across 96 round(s). With a team of 11-50 employees, Carmot Therapeutics is actively contributing to advancements in Biotechnology. Their latest funding round, Venture Round - Carmot Therapeutics, raised $500.2K. Discover more about their projects, partnerships, and impact on our platform.
Funding Rounds
Funding rounds
8
Investors
1
Lead Investors
0
Total Funding Amount
$384.8M
Details
5
Carmot Therapeutics has raised a total of $384.8M in funding over 5 rounds.
| Announcement date | Transaction name | Number of Investors | Money raised | Lead Investor |
|---|---|---|---|---|
| 2020 | Late Stage Venture | 47.0M | ||
| 2022 | Late Stage Venture | 160.0M | ||
| 2023 | Late Stage Venture | 150.0M | ||
| 2010 | Early Stage Venture | 1.5M |
Investors
Carmot Therapeutics is funded by 42 investors.
| Investor Name | Lead Investor | Funding Round | Partners |
|---|---|---|---|
| Franklin Templeton | - | FUNDING ROUND - Franklin Templeton | 150.0M |
| Peter Svennilson | - | FUNDING ROUND - Peter Svennilson | 1.5M |
| Carmot Therapeutics | - | FUNDING ROUND - Carmot Therapeutics | 1.5M |
| The Column Group | - | FUNDING ROUND - The Column Group | 1.5M |
Recent Activity
There is no recent news or activity for this profile.